DEPLOY

ExplainersHumanoid robots

What is Fourier Intelligence and the GR-3 humanoid?

Fourier Intelligence is a Chinese humanoid robotics company headquartered in Shanghai with distinctive technical heritage in lower-limb exoskeleton and rehabilitation robotics. The GR-3 is the company's third-generation general-purpose humanoid platform, evolved from the GR-1 and GR-2 predecessors. Fourier occupies a distinctive position in the Chinese humanoid cohort: medical and rehabilitation engineering heritage transitioning to general-purpose humanoid product, with research-platform commercial positioning rather than the factory-deployment focus of UBTech Walker S2 or the research-tools pricing of Unitree G1 and R1.

Shanghai
Headquarters
verified
GR-3
Current generation
verified
3rd generation
GR-1 → GR-2 → GR-3 lineage
verified
Rehabilitation
Technical heritage origin
verified
Research-platform
Commercial positioning
verified
Mid-2026
Snapshot date
verified
verifiedstatedclaimedabsence

Chinese humanoid maker with rehabilitation robotics heritage

Per registry source-of-truth, Fourier Intelligence is a humanoid robotics company headquartered in Shanghai, China. The company's technical heritage runs through lower-limb exoskeleton and rehabilitation robotics rather than warehouse-and-factory engineering most US + Chinese humanoid cohort members trace back to. This is editorially distinctive: Fourier's research lineage produces different engineering priors (rehabilitation context emphasizes safety-around-humans + fine-grained force control + human-environment compatibility). Privately held; emerging-manufacturer tier per DEPLOY's 5-tier availability framework.

GR-3 third-generation general-purpose humanoid platform

GR-3 is Fourier's flagship general-purpose humanoid platform, evolved from GR-1 + GR-2 predecessors. The generation-to-generation lineage shapes verification posture: each generation reflects cumulative engineering refinement rather than green-field rewrite. Per registry source-of-truth, Fourier's commercial positioning emphasizes research-platform availability with rehabilitation + assistive-technology context. The platform ships to research and rehabilitation customers; verification surface is research-customer relationships rather than scaled-throughput commercial deployment.

Chinese humanoid cohort is NOT a single editorial bloc

Per DEPLOY's framework, the four major Chinese humanoid manufacturers operate structurally distinct commercial theses: Unitree G1 + R1: research-tools pricing strategy (low-cost catalog availability for research + developer customers). UBTech Walker S2: factory-and-industrial-pilot positioning (HKEX-listed; BYD + Geely + Foxconn customers). AgiBot: emerging-flagship positioning (general-purpose humanoid with consumer + industrial scope). Fourier GR-3: rehabilitation-and-medical-context positioning evolving toward general-purpose humanoid. The four positions illustrate framework readings should preserve cohort differentiation rather than collapsing into generic geographic category.

Rehabilitation positioning matters editorially

Fourier's rehabilitation heritage is not a marketing footnote. The research lineage produces engineering priors that distinguish GR-3's product positioning: (1) Safety around humans is the design starting point, not afterthought; rehabilitation context requires force-control + fall-prevention + human-environment compatibility warehouse-and-factory engineering does not always foreground. (2) Assistive-task context shapes capability framing; GR-3 product hypothesis tilts toward human-assistance rather than human-replacement. (3) Generation-to-generation iteration emphasizes engineering refinement over green-field rewrites; distinct commercial trajectory from US peers that founded specifically to ship current product (Figure AI + Apptronik) versus Fourier's prior product line evolved into humanoid context.

Scaled commercial throughput cap-flagged per registry-source-of-truth

Per DEPLOY's verified-vs-claimed framework, scaled commercial throughput at the depth of Apptronik Apollo's three-customer enterprise breadth, Agility Digit's GXO Flowery Branch 100,000-tote single-customer depth, or Figure 02 at BMW Spartanburg's 30,000-vehicles automotive-OEM acceptance has NOT landed for GR-3. The cap-flag is the editorial truth, not a gap. GR-3 sits at emerging-manufacturer tier with research-platform availability; verified consumer-deployment or scaled enterprise-deployment is not the current state. Whether rehabilitation heritage produces commercial advantage at deployment scale is forward operator question.


Fourier Intelligence: institutional facts

Fourier Intelligence is a humanoid robotics company headquartered in Shanghai, China. The company's technical heritage runs through lower-limb exoskeleton and rehabilitation robotics rather than the warehouse-and-factory engineering most US and Chinese humanoid cohort members trace back to. This is editorially distinctive: Fourier's research lineage produces a different set of priors about how humanoid platforms should be engineered (rehabilitation context emphasizes safety-around-humans, fine-grained force control, and human-environment compatibility).

Fourier is privately held. For broader investor-disambiguation context across the humanoid cohort, see best humanoid manufacturer to invest in. For the Chinese humanoid cohort context (Fourier alongside Unitree, UBTech, AgiBot, and several others), see which humanoid robots are American vs Chinese.


GR-3 as third-generation Fourier humanoid

The GR-3 is Fourier's flagship general-purpose humanoid platform, evolved from GR-1 and GR-2 predecessors. The generation-to-generation lineage shapes the verification posture: each generation reflects cumulative engineering refinement rather than a green-field rewrite. Fourier's commercial positioning emphasizes research-platform availability with rehabilitation and assistive-technology context, distinct from peer Chinese humanoid manufacturer positioning:

  • Unitree G1 + R1: research-tools pricing strategy (low-cost catalog availability for research and developer customers).
  • UBTech Walker S2: factory-and-industrial-pilot positioning (HKEX-listed; BYD / Geely / Foxconn customers).
  • AgiBot: emerging-flagship positioning (general-purpose humanoid with consumer + industrial scope).
  • Fourier GR-3: rehabilitation-and-medical-context positioning evolving toward general-purpose humanoid.

The four positions illustrate that the "Chinese humanoid cohort" is not a single editorial bloc. Each major Chinese manufacturer operates a structurally distinct commercial thesis; framework readings should preserve this differentiation rather than collapsing the cohort into a generic geographic category.


What the framework verifies and what it does not

Applying DEPLOY's verified-vs-claimed framework to Fourier Intelligence GR-3:

  • Company verified: Fourier is a real Shanghai-headquartered company with multi-year operational history in rehabilitation robotics. The transition to general-purpose humanoid is verifiable through product-launch communications and research publications.
  • GR-3 product verified at research-platform scale: the platform ships to research and rehabilitation customers; the verification surface is research-customer relationships rather than scaled-throughput commercial deployment.
  • Five-tier availability: GR-3 sits at the emerging-manufacturer tier with research-platform availability context. The platform is purchasable via Fourier's commercial channels at research-and-institutional pricing tier; see DEPLOY's pricing page for Fourier GR-3 for consumer-evaluation context.
  • Four-tier capability: GR-3 operates primarily at the research-and-demonstration tier (with rehabilitation-and-assistive context as the distinctive demonstration domain). Verified consumer-deployment or scaled enterprise-deployment is not the current state.
  • Cap-flag: scaled commercial throughput at the depth of Apptronik Apollo's three-customer enterprise breadth, Agility Digit's GXO Flowery Branch single-customer 100,000-tote depth, or Figure 02 at BMW Spartanburg's automotive-OEM acceptance has not landed for GR-3. The cap-flag is the editorial truth, not a gap.

Rehabilitation positioning matters editorially

Fourier's rehabilitation heritage is not a marketing footnote. The research lineage produces engineering priors that distinguish GR-3's product positioning:

  • Safety around humans is the design starting point, not an afterthought. Rehabilitation context requires force-control, fall-prevention, and human-environment compatibility that warehouse-and-factory engineering does not always foreground.
  • Assistive-task context shapes capability framing. The GR-3 product hypothesis tilts toward human-assistance rather than human-replacement, which matters for how the platform's task envelope is articulated.
  • Generation-to-generation iteration emphasizes engineering refinement over green-field rewrites. This is a different commercial trajectory from US peers that founded the company specifically to ship the current product (Figure AI, Apptronik) versus Fourier's prior product line evolved into humanoid context.

Whether the rehabilitation heritage produces commercial advantage at deployment scale is a forward operator question. The framework reads Fourier's positioning as a distinct editorial posture within the Chinese humanoid cohort, with verification surfaces accumulating per deployment customer rather than at aggregate-throughput depth.


Where to go for context

For consumer-evaluation context on Fourier GR-3, see DEPLOY's pricing page for GR-3. For canonical institutional depth at the registry layer (founding history, leadership, deployment record, source-depth verification across available sources), see Fourier Intelligence's registry record.

For Chinese humanoid cohort comparison context, see Unitree G1 + R1 pricing, UBTech Walker S2, and which humanoid robots are American vs Chinese.

For the broader humanoid availability and capability frameworks, see can I buy a humanoid robot in 2026 and what can humanoid robots actually do today. For methodology canonical references applicable to Fourier GR-3: the 4-way autonomy-boundary taxonomy (Chinese cohort consumer-pricing tier) + the 9-tier source-quality rubric.


Fourier GR-3 vs Chinese humanoid cohort by commercial thesis (mid-2026)Fourier (GR-3)Unitree (G1 + R1)UBTech (Walker S2)AgiBotXPeng (Iron)Xiaomi (CyberOne)
Commercial thesis
Rehabilitation + medical → general-purpose humanoid
Research-tools pricing (low-cost catalog)
Factory-and-industrial-pilot
Emerging-flagship general-purpose
Automotive-OEM heritage; consumer + industrial
Consumer ecosystem + emerging humanoid
Tier position
Emerging-manufacturer
Research-tools
Enterprise-pilot
Emerging-manufacturer
Emerging-manufacturer
Emerging-manufacturer
Verification anchor
Research platform
Verified pricing
HKEX + named pilots
Emerging
Emerging
Emerging

Sources: Source: DEPLOY registry + per-entity operational records + per-maker public communications. Chinese cohort + commercial thesis + verification posture framework.

Frequently Asked Questions


What is Fourier Intelligence?

Fourier Intelligence is a Chinese humanoid robotics company headquartered in Shanghai, China with distinctive technical heritage in lower-limb exoskeleton + rehabilitation robotics. The GR-3 is the company's third-generation general-purpose humanoid platform, evolved from GR-1 + GR-2 predecessors. Fourier occupies a distinctive position in the Chinese humanoid cohort: medical + rehabilitation engineering heritage transitioning to general-purpose humanoid product. Privately held; emerging-manufacturer tier per DEPLOY framework.


What is the GR-3 humanoid?

GR-3 is Fourier Intelligence's third-generation general-purpose humanoid platform, evolved from GR-1 + GR-2 predecessors. The platform reflects cumulative engineering refinement rather than green-field rewrite. Fourier's commercial positioning emphasizes research-platform availability with rehabilitation + assistive-technology context. GR-3 ships to research and rehabilitation customers; the verification surface is research-customer relationships rather than scaled-throughput commercial deployment. Per DEPLOY's framework, GR-3 sits at emerging-manufacturer tier with research-platform availability context.


Where is Fourier Intelligence based?

Per registry source-of-truth, Fourier Intelligence is headquartered in Shanghai, China. The company is part of the Chinese humanoid cohort alongside Unitree (Hangzhou), UBTech (Shenzhen), AgiBot (Shanghai), XPeng Robotics (Guangzhou), Xiaomi Robotics (Beijing), and several other emerging Chinese humanoid manufacturers. For broader geographic disambiguation, see which humanoid robots are American vs Chinese.


How does Fourier differ from Unitree and UBTech?

Distinct commercial theses per DEPLOY's framework. Fourier (GR-3): rehabilitation + medical → general-purpose humanoid; research-platform availability; emerging-manufacturer tier. Unitree G1 + R1: research-tools pricing strategy (low-cost catalog availability $5,900-$16,000 for research + developer customers); verified-pricing anchor. UBTech Walker S2: factory-and-industrial-pilot positioning; HKEX-listed; BYD + Geely + Foxconn customers. The three positions illustrate the Chinese humanoid cohort is NOT a single bloc; each major Chinese maker operates structurally distinct commercial thesis.


Can I buy a Fourier GR-3?

Per registry source-of-truth, GR-3 ships to research and rehabilitation customers; available through Fourier's commercial channels at research-and-institutional pricing tier. See DEPLOY's pricing page for Fourier GR-3 for consumer-evaluation context. Per DEPLOY's framework, GR-3 sits at emerging-manufacturer tier with research-platform availability; the platform is purchasable but not at consumer-deployment scale or scaled-enterprise commercial depth. Scaled commercial throughput cap-flagged against Apptronik + Agility + Figure deployment anchors.


Is Fourier Intelligence publicly traded?

No. Per registry source-of-truth, Fourier Intelligence is privately held. No public stock listing; investors interested in equity exposure cannot buy shares directly. Per DEPLOY's framework, the privately-held capital structure is editorially substantive: Fourier operates as venture-stage Chinese humanoid manufacturer alongside privately-held cohort members. For broader investor-disambiguation context across the humanoid cohort, see best humanoid manufacturer to invest in. The cap-flagged private-company verification posture is structurally distinct from public-company verification depth (e.g. UBTech HKEX-listed).

Defined terms in this explainer

More in humanoid robots

View all 46 explainers in humanoid robots

← All explainers